Phase in Biological Technology
Navigation Links
Phase in Biological Technology
Novavax Reports Second Quarter 2009 Financial Results
... Completed subject enrollment in the second phase II study of its trivalent season influenza ... authorities, will be formed and funded to support phase III clinical development and other studies ... Release top-line results from the phase II trial in healthy adults with our trivalent ...Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results
... "We are currently evaluating the data from our phase II clinical trial evaluating the use of CPP-109 ... and non-clinical trials." Publication of phase II Mexican Cocaine Trial Results A paper ... results obtained in an investigator-initiated phase II trial conducted in Mexico in 2007 was ...InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
... monkeys, respectively which clear the way for our phase 2 and phase 3 clinical programs; our expectation that our partner Roche will enroll the first patient in our phase 2b study of ITMN-191 in combination with standard ...OncoGenex Reports Second Quarter 2009 Financial Results
... survival follow-up for previously announced phase 2 clinical trials of OGX-011; - completion of its phase 1 clinical trial evaluating OGX-427 as a ... - initiation of an investigator-sponsored phase 1 clinical trial evaluating OGX-427 ...... to treat solid tumors. OMP-21M18 is currently in phase 1 clinical testing. "OMP-21M18 ... differentiation. OMP-21M18 is currently in a phase 1 clinical trial in patients with advanced solid ... lead candidate, OMP-21M18 is currently in phase I clinical trials. In addition to OMP-21M18, ...
Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC-305
... an application with health authorities to begin phase I clinical testing for CUDC-305 in Fall 2009. ... that is currently enrolling patients in a phase I dose escalation trial, as well as our other ... of 2010 from our collaborator Genentech's ongoing phase II clinical trials of GDC-0449, a Hedgehog ...Repligen Reports First Quarter Fiscal Year 2010 Financial Results
... spending associated with advancement of both our phase 3 clinical trial of RG1068 for pancreatic imaging, and our phase 2b clinical trial of RG2417 for bipolar ... we expect to receive pivotal data from both our phase 3 pancreatic imaging ...Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
... over the last few months. We presented important phase 2 data on both our compounds, regained full ... Capital Market, and announced our SPA for the phase 3 trial of perifosine in multiple myeloma. We ... our discussions with the FDA regarding the U.S. phase 3 program for Zerenex shortly, at which time ...Amicus Therapeutics Announces Second Quarter 2009 Financial Results
... lead program, Amigal for Fabry disease, entering phase 3 development." Crowley continued, "This is a ... H regulations. Amicus has begun submitting the phase 3 protocol to investigational sites worldwide and ... of this year. As previously announced, the phase 3 trial will evaluate the efficacy, safety, and ...Pharmasset to Present at Canaccord Adams Conference
... analog for chronic HCV infections, is in a phase 2b clinical trial in combination with Pegasys(R) ... HCV nucleotide analog which recently began phase 1 clinical studies and Racivir, for the treatment of HIV, which has completed a phase 2 clinical trial. Pegasys((R)) and ...GeoVax Labs, Inc. Provides Clinical Studies Update
... of GeoVax Labs, Inc. "The results of the early phase 1 clinical work for the preventative version of ... company to move up to another level of analysis, phase 2a human clinical trial. This trial was ... we are in the midst of planning the details of a phase 1 human clinical trial and expect to begin this ...Shire plc: Core Portfolio of Products Delivers 20% Sales Growth
... clear commercial benefits, as we enter a new phase of Shire's development. We have ... of 2009 as planned. We are also initiating phase 2 pilot clinical trials to assess the efficacy ... indications in adults - Shire is conducting phase 2 pilot clinical trials to assess the ...... testing of patients enrolled in the company's phase 2 trial of CERE-120 for Parkinson's disease. The ... 2008. As was previously announced, the phase 2 trial of CERE-120 involving 52 patients, failed ... We learned a significant amount from the initial phase 2 trial which enabled us to design a protocol ...
Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results
... first oral presentations of our North American phase 3 fidaxomicin data at major scientific ... are focused on completing our second fidaxomicin phase 3 trial and preparing regulatory filings for ... data from Optimer's fidaxomicin North American phase 3 clinical study for patients with Clostridium ...... today announced positive results from a phase 2 clinical trial of radezolid in the treatment of ... by the positive results we've seen in this phase 2 trial of radezolid in community-acquired ... the previously reported positive results of the phase 2 trial in uncomplicated skin infections, we are ...
Omeros Appoints New Vice President of Clinical Development
... the Company's lead candidate being evaluated in a phase 3 clinical program for improved joint function ... following arthroscopic surgery, OMS302 in a phase 2 program for use in cataract surgery, and OMS201 in a phase 1/2 program for use in uroendoscopy. "Dr. ...... Oncology Annual Meeting, we reported promising phase 2 picoplatin data from our colorectal and ... on track to report results from our pivotal phase 3 SPEAR trial of picoplatin in small cell lung ... neurotoxicity data from a randomized, controlled phase 2 trial of picoplatin for the first-line ...
... complexes. Zerenex has recently completed a phase 2 clinical program as a treatment for ... and cell survival. KRX-0401 is currently in phase 2 clinical development for multiple tumor types, with a phase 3 in multiple myeloma, under SPA, pending ...
Micromet Closes $80.5 Million Public Offering of Common Stock
... Its BiTE antibody blinatumomab (MT103) is in a phase 2 clinical trial for the treatment of patients with acute lymphoblastic leukemia (ALL), and in a phase 1 clinical trial for the treatment of patients ... (NHL). A second BiTE antibody, MT110, is in a phase 1 clinical trial for the treatment of patients ...... today announced dosing of its first patient in a phase 2 clinical study of its lead product, CD-NP, for ... The single-blind, placebo-controlled phase 2 study is designed to provide additional ... Previously reported results of a phase 1b study in chronic heart failure patients showed ...
VIVUS to Present at the Canaccord Adams 29th Annual Global Growth Conference
... development, Qnexa(TM), is expected to complete phase 3 clinical trials for the treatment of obesity in 2009. Qnexa is also in phase 2 clinical development for the treatment of type ... In the area of sexual health, VIVUS is in phase 3 development with avanafil, its PDE5 inhibitor ...... with orBec((R)). The first trial was a 60-patient phase 2 single-center clinical trial conducted at the ... The second trial was a 129-patient pivotal phase 3 multi-center clinical trial conducted at 16 ... 0.0139). At one year post randomization in the phase 3 trial, 18 patients (29%) in the orBec(R) group ...
... clinical trial data gathered while conducting phase I clinical trials. phase I clinical trials are the first stage of the US ... The Logos products cover all aspects of the phase I process from subject recruitment and clinical ...
... had achieved its primary endpoint in an ongoing phase 2 study of ALL patients. The company presented ... (MRD)(1). The patients included in this phase 2 clinical trial were in complete hematological ... leukemia (ALL): Update of an ongoing phase II study. 14th Congress of the EHA 2009, abstract ...
Oncothyreon announces presentation of long-term Stimuvax data at World Conference on Lung Cancer
... for between 2 and 8.2 years as part of the phase 2b trial in patients with stage IIIb/IV non-small ... of autoimmune reactions with prolonged use. The phase 2b trial of Stimuvax in patients with stage ... from Oncothyreon and is currently conducting phase 3 trials of Stimuvax in both NSCLC and breast ...... Protocol Assessment (SPA) on the design of a phase 3 trial for the Company's PI3K/Akt pathway ... (VELCADE(R)). The SPA provides agreement that the phase 3 study design adequately addresses objectives in ... a regulatory submission. The study, entitled, "A phase 3 Randomized Study to Assess the Efficacy and ...
OncoGenex Pharmaceuticals to Release Second Quarter 2009 Financial Results
... the lead candidate that has completed five phase 2 clinical trials in prostate, lung and breast ... with treatment resistance; OGX-427 is in phase 1 clinical development; SN2310 has completed the phase 1 clinical trial; and CSP-9222 and OGX-225 are ...... of 53 clinical studies including 2 pivotal phase 3 studies in CAP and a safety database of over ... CAP indication. Advanced Life Sciences' pivotal phase 3 program included in the NDA was designed and ... to develop a protocol for an additional phase 3 trial that is designed to satisfy the FDA's ...
... The company recently announced positive phase 2 results for Oral NKTR-118, its proprietary ... NKTR-102, PEGylated irinotecan, is currently in phase 2 clinical studies in ovarian, breast and ... NKTR-105, PEGylated docetaxel, is currently in a phase 1 study in patients with refractory solid tumors. ...
... The company recently announced positive phase 2 results for Oral NKTR-118, its proprietary ... NKTR-102, PEGylated irinotecan, is currently in phase 2 clinical studies in ovarian, breast and ... NKTR-105, PEGylated docetaxel, is currently in a phase 1 study in patients with refractory solid tumors. ...
... finalization of the protocol for the Company's phase II trial of ANA598 in combination with pegylated ... within the next several weeks. In the phase II study, naive genotype 1 patients will receive ... and good tolerability as a single agent in phase I, as well as preclinical properties indicative ...
Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights
... cash position, reduced cost structure and phase II protocol allowance from the FDA, we are well ... antiviral activity and good tolerability in phase I, as well as preclinical properties indicative ... clinically in combination regimens. The upcoming phase II trial has several important elements, ...Senesco Technologies Enters Into Agreements For Additional $700,000 In Financing
... program with the emphasis on initiating a phase I clinical trial for multiple myeloma. ... development program with the goal of initiating a phase I clinical trial. "We are excited by the ... New Drug Application and initiating a phase I clinical trial for SNS-01." Important ...... solutions in connection with two of the CRO's phase IV studies covering approximately 27 sites and ... subjects. Additional details were not disclosed. phase IV studies take place after a drug has been ... provide eClinical solutions for these important phase IV studies," said Cornelis F. Wit, OmniComm's ...
Micromet Announces Pricing of Public Offering of Common Stock
... Its BiTE antibody blinatumomab (MT103) is in a phase 2 clinical trial for the treatment of patients with acute lymphoblastic leukemia (ALL), and in a phase 1 clinical trial for the treatment of patients ... (NHL). A second BiTE antibody, MT110, is in a phase 1 clinical trial for the treatment of patients ...... study in these infections based on the successful phase II results in treating other chronic lung ... distribution in the lungs. Positive phase II results were announced in June 2008 from a ... completion of enrollment in two additional phase II trials including a study where ARIKACE is ...
Oncolytics Biotech(R) Inc. Announces 2009 Second Quarter Results
... Highlights - Presented updated U.S. phase II sarcoma trial data at the American ... of REOLYSIN and gemcitabine in a U.K. phase I trial was well tolerated, and resulted ... and demonstrated anti-tumour activity in a U.S. phase I systemic administration monotherapy ...Micromet Announces Public Offering of Common Stock
... Its BiTE antibody blinatumomab (MT103) is in a phase 2 clinical trial for the treatment of patients with acute lymphoblastic leukemia (ALL), and in a phase 1 clinical trial for the treatment of patients ... (NHL). A second BiTE antibody, MT110, is in a phase 1 clinical trial for the treatment of patients ...Sangamo BioSciences Reports Second Quarter 2009 Financial Results
... Highlights Presentation of positive phase 2 ZFP Therapeutic data at ADA 2009. Sangamo ... presentation of previously unreleased positive phase 2 clinical data from its ZFP Therapeutic(TM) ... Data from Sangamo's SB-509-601 and SB-509-701A phase 2 clinical trials demonstrated that SB-509 ...... month safety and efficacy results from its fourth phase II clinical trial using its proprietary, ... and consistent with results across the entire phase II program. Dr. O'Brien also commented, ... appears to be the optimal choice for upcoming phase III trials." There were no signals of ...
Other ContentsstitchesstitchesstimulantsstimulantsstimulantsstimulusstimulusstimulusstimulusstimulusstimulusflufluflufluflustoolsstoolsstoolsstoolstoolstoolstoolstoolbitebitebitebitebiteOther TagsKateallocateLogicalLogicalLogicalLogicalLogicalLogicalOther Tagsfun 2fun 3hole 2hole 3
(Date:11/30/2009)...temperatures continue to rise scientists are prese...ow species respond and adapt. In a paper published...sco Rodriguez-Trelles and Dr Miguel Rodriguez asse...rming of approximately 0.6˚C has already affe... facing ecologists and evolutionary biologists is ...
(Date:11/30/2009)... , VILNIUS, Lithuania, Nov. 30 ...), a provider of high-precision biometric identifi... in the company,s core product line: VeriLook 4....ition and MegaMatcher 3.1 SDK for large-scale mu...tion systems (AFIS). Expanded capabilities in Veri...
(Date:11/26/2009)...arried out in eight European countries has shown t...disease pandemic could have a significant role in ... in the open access journal BMC Infectious Diseas... days and weekends/holidays, finding that they wer...om Hasselt and Antwerp University, Belgium, led a ...
Breaking Biology News(10 mins):How can scientists measure evolutionary responses to climate change? 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 3School closure could reduce swine flu transmission by 21 percent 2Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science 26amp 3B Technology Conference 14897 1Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science 26amp 3B Technology Conference 14897 2Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science 26amp 3B Technology Conference 14897 3Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science 26amp 3B Technology Conference 14897 4Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science 26amp 3B Technology Conference 14897 5Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science 26amp 3B Technology Conference 14897 6Benevolence Beyond Politics Inc Announces Position to Provide Financial and Logistical Support for Humanitarian and Medical Missions Worldwide 6372 1Benevolence Beyond Politics Inc Announces Position to Provide Financial and Logistical Support for Humanitarian and Medical Missions Worldwide 6372 2Merz Pharmaceuticals Announces Approval of Post stroke Upper Limb Spasticity Indication for Xeomin 28R 29 in the EU 6368 1Merz Pharmaceuticals Announces Approval of Post stroke Upper Limb Spasticity Indication for Xeomin 28R 29 in the EU 6368 2Merz Pharmaceuticals Announces Approval of Post stroke Upper Limb Spasticity Indication for Xeomin 28R 29 in the EU 6368 3Merz Pharmaceuticals Announces Approval of Post stroke Upper Limb Spasticity Indication for Xeomin 28R 29 in the EU 6368 4(Date:11/30/2009).... 30 - Salon Leau announced today t...mber 7(th) to raise funds and create positive impa...s. All proceeds from each haircut and or color wil...tal. ,, Salon Leau has been serving the posh W...y LoAnn Lai, widely recognized for her innovation ...
(Date:11/30/2009)....J., Nov. 30 Advanced Health Media...logistics, speaker programs and commercial complia...stry, announced it has been named the second faste...ey,s leading statewide business newspaper. AHM wa...have made significant contributions to the state,s...
(Date:11/30/2009)...ease Control and Prevention estimate that well ove...cted with HIV/AIDS. New research from North Caroli...ted are minorities and do not have health insuranc... to facilitate education and prevention efforts in...arch, which analyzed 90,000 HIV patient hospital v...
(Date:11/30/2009)...gravy and dessert at the holiday table are even le...ught. According to a new research report recently ...ww.fasebj.org ), a diet that is high in fat and in...cause our bodies to store too much fat. This means...lready difficult task of converting high-fat and h...
(Date:11/30/2009)...Peter J. Rappa, MD, explores the intricate connect..."Healing Heart to Soul: One Doctor’s Jo...oks 2009). , Dallas, TX (...sing to let go of negative emotions, whether cause... our shoulders. Oftentimes, this disease of the hu...
Breaking Medicine News(10 mins):Health News:Georgetown Hair Salon Helps St. Jude Find A Cure 2Health News:Advanced Health Media Honored at NJ Finest Award Ceremony 2Health News:Research highlights need for national HIV strategy 2Health News:Western diets turn on fat genes 2Health News:Healing from the Inside Out: Compelling New Book Explores the Intricate Connection between Body, Soul, and Better Health 2[0] Georgetown Hair Salon Helps St. Jude Find A Cure[0] Advanced Health Media Honored at NJ Finest Award Ceremony[0] Research highlights need for national HIV strategy[0] Western diets turn on fat genes[0] Healing from the Inside Out: Compelling New Book Explores the Intricate Connection between Body, Soul, and Better Health
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |